Hepatitis E virus also attacks organs other than the liver, study finds
A research team from Bochum and Hannover shows that the hepatitis E virus also attacks organs other than the liver. ...
Tag: Hepatitis
New intercellular network found to drive liver fibrosis progression
Liver fibrosis, a pathological condition in which the liver becomes stiff and scarred, commonly develops in the progression of chronic ...
Circular RNAs emerge as key players in hepatitis B-related liver cancer
Hepatitis B virus-induced hepatocellular carcinoma (HCC) remains a major global health burden, and new therapeutic and diagnostic approaches are urgently ...
A safer and more affordable polio vaccine could soon be a reality
A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found. Researchers ...
Study evaluates effectiveness and safety of TMF for chronic hepatitis B
Background and aims Chronic hepatitis B (CHB) remains a significant global health challenge, and effective antiviral therapies are essential for ...
Shiitake-based supplement may help prevent liver damage progression
Early use of AHCC during hepatitis stages shows potential to reduce the risk of cirrhosis, according to new research Study: ...
Telemedicine and peer support show promise in treating hepatitis C in rural areas
New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both ...
Innovative tool enhances the accuracy of predicting survival outcomes for liver failure patients
Researchers have unveiled a groundbreaking advancement in liver failure care: the CATCH-LIFE-MELD score (Chinese Acute-on-Chronic Liver Failure Consortium (CATCH-LIFE)-MELD score). ...
Imbalances in NET homeostasis linked to portal vein thrombosis in CHB-related decompensated cirrhosis
Background and aims Portal vein thrombosis (PVT) is a challenging complication in liver cirrhosis, with no currently available sensitive diagnostic ...
Advancing vaccine development through green biotechnology
The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each ...